These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38189)

  • 21. [Parkinson's disease and parkinsonian syndromes].
    Pollack P; Gaio JM; Perret J
    Rev Prat; 1989 Mar; 39(8):647-51. PubMed ID: 2727571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease: a clinical review.
    Lieberman AN
    Am J Med Sci; 1974 Feb; 267(2):66-80. PubMed ID: 4821328
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and neurobiologic implications of antipsychotic-induced movement disorders.
    Rubin EH; Zorumski CF
    Compr Ther; 1986 Oct; 12(10):61-7. PubMed ID: 2877769
    [No Abstract]   [Full Text] [Related]  

  • 24. Phenomenological approach to the correct diagnosis of Parkinson's disease.
    Metzer WS
    J Ark Med Soc; 1992 May; 88(12):607-9. PubMed ID: 1601829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric movement disorders.
    Saunders-Pullman R; Braun I; Bressman S
    Child Adolesc Psychiatr Clin N Am; 1999 Oct; 8(4):747-65, viii. PubMed ID: 10553201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to minimize side effects of psychoactive drugs.
    Sloan RW
    Geriatrics; 1982 May; 37(5):51-5, 60, 62 passim. PubMed ID: 6121741
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosing non-parkinson's movement disorders.
    Lewis S; Liddle J
    Practitioner; 2012 Feb; 256(1748):21-4, 3. PubMed ID: 22497105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential diagnosis of common tremor syndromes.
    Bhidayasiri R
    Postgrad Med J; 2005 Dec; 81(962):756-62. PubMed ID: 16344298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethosuximide and tremor in Parkinson's disease: a pilot study.
    Pourcher E; Gomez-Mancilla B; Bédard PJ
    Mov Disord; 1992; 7(2):132-6. PubMed ID: 1350060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tremor and Parkinson's disease.
    Boddie H
    Practitioner; 1989 Aug; 233(1473):1101-2. PubMed ID: 2602338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive tremor.
    Stacy M; Jankovic J
    Mov Disord; 1992; 7(1):53-7. PubMed ID: 1348352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the early signs of drug induced parkinsonism.
    Arblaster LA; Lakie M; Mutch WJ; Semple M
    J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):301-3. PubMed ID: 8096240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium.
    Lawrence JM
    Psychosomatics; 1985 Nov; 26(11):869-74, 877. PubMed ID: 2867577
    [No Abstract]   [Full Text] [Related]  

  • 35. [Functional decerebration presenting the picture of an apallic syndrome due to high dosage majeptil therapy. A contribution to the question of the mode of action and site of attack of certain neuroleptics].
    Bruck J; Gerstenbrand F
    Nervenarzt; 1967 Oct; 38(10):459-64. PubMed ID: 4383207
    [No Abstract]   [Full Text] [Related]  

  • 36. [Abnormal movements observed during treatment of Parkinson's disease with L-dopa].
    Sigwald J; Raymondeaud C
    Rev Neurol (Paris); 1970 Feb; 122(2):103-12. PubMed ID: 4397165
    [No Abstract]   [Full Text] [Related]  

  • 37. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurological syndromes associated with antipsychotic drug use. A special report.
    Freedman DX
    Arch Gen Psychiatry; 1973 Apr; 28(4):463-7. PubMed ID: 4692143
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 40. Hydroxyzine hydrochloride: possible adverse cardiac interactions.
    Hollister LE
    Psychopharmacol Commun; 1975; 1(1):61-5. PubMed ID: 4857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.